Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ondansetron (2mg) Injection
Therapeutic Category
Gastroenterology, General and OTC medicines
Dosage Form
Injection
Packaging Type
vial
Packaging
10*2 ml
Price
₹13.35/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ondotyle Injection, containing Ondansetron (2mg), is a fast-acting antiemetic designed to prevent and treat nausea and vomiting in various medical situations. Ondansetron, a selective serotonin (5-HT3) receptor antagonist, works by blocking the action of serotonin in the brain and gastrointestinal tract, which are key triggers for nausea and vomiting. This makes it highly effective for use during chemotherapy, radiotherapy, and after surgical procedures, where these symptoms are common.
Ondotyle Injection is administered intravenously or intramuscularly, ensuring rapid action and providing relief when oral administration is not feasible. Its targeted mechanism of action and reliable efficacy make it a preferred choice for healthcare professionals in managing acute and severe cases of nausea and vomiting.
Common side effects may include headache, dizziness, constipation, or mild abdominal discomfort. Rare but serious effects such as allergic reactions, irregular heartbeat, or changes in blood pressure may occur.
Ondotyle Injection is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, postoperative recovery, and gastrointestinal disturbances.
This injection should only be administered under the supervision of a qualified healthcare professional. Do not exceed the recommended dose. Discontinue use and consult a doctor immediately if adverse effects occur.
Store below 25°C in a cool, dry place, protected from light. Keep out of reach of children.
Composition : Ondansetron (8 mg) MD
Composition : Ondansetron (2mg)
Composition : Ondansetron (4mg) MD
Composition : Granisetron (1mg) Injection
Composition : Drotaverine (80mg) + Mefenamic Acid (250mg)
Composition : Doxylamine (20mg) + Vitamin B6 (Pyridoxine) (20mg) + Folic Acid (5mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This injectable combination has strong demand in the hospital and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on emergency care and gastro care portfolios.
Medical distributors and agencies can benefit from consistent hospital demand for management of nausea, vomiting, acidity, gastric irritation, gastritis, and post-operative gastric discomfort. Ondansetron helps control nausea and vomiting, while Ranitidine helps reduce stomach acid production, strengthening a comprehensive hospital care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this injectable combination with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital and institutional demand, emergency and post-operative care usage, reliable supply chain support, and good margins when partnering for this hospital care product.
Medical distributors, stockists, and wholesalers interested in this injectable combination can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.